Takuji Okusaka
International University of Health and Welfare
623 Papers
3K Citations
Takuji Okusaka is an academic researcher from International University of Health and Welfare. The author has contributed to research in topics: Medicine & Gemcitabine. The author has an hindex of 67, co-authored 490 publications. Previous affiliations of Takuji Okusaka include National Cancer Research Institute & Kyorin University.
Chat about Author
Papers
Tolerability of Nab-Paclitaxel Plus Gemcitabine as Adjuvant Setting in Japanese Patients With Resected Pancreatic Cancer: Phase I Study.
Makoto Ueno,Soichiro Morinaga,Yusuke Hashimoto,Kumiko Umemoto,Naoki Sasahira,Akio Saiura,Yasuji Seyama,Goro Honda,Tatsuya Ioka,Hidenori Takahashi,Atsushi Miyamoto,Shoji Nakamori,Michiaki Unno,Tatsuyuki Takadate,Nobumasa Mizuno,Yasuhiro Shimizu,Hideki Ueno,Masanori Sugiyama,Akira Fukutomi,Satoshi Shimizu,Takuji Okusaka,Junji Furuse +21 more
TL;DR: These results show that adjuvant GnP is tolerable in Japanese patients with resectable pancreatic cancer, as well as safety, disease-free survival, and overall survival.
2
Ramucirumab in patients with advanced hepatocellular carcinoma (HCC) and elevated alpha fetoprotein (AFP): An exposure-response analysis
Josep M. Llovet,Masatoshi Kudo,Y-K. Kang,C.-J. Yen,Richard S. Finn,Peter R. Galle,Eric Assenat,Kenta Motomura,Takuji Okusaka,T. Berg,C.-H. Hsu,Masafumi Ikeda,Yanzhi Hsu,Kun Liang,Ryan C. Widau,William R. Schelman,L. O’Brien,Ling Gao,Andrew X. Zhu +18 more
2
A phase II trial of hepatic arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma with portal vein tumor thrombosis
Junji Furuse,Masataka Ikeda,Takuji Okusaka,Kohei Nakachi,Chigusa Morizane,H. Ueno,H. Yamaura,Yoshitaka Inaba,Mitsuo Satake,Yasuaki Arai +9 more
TL;DR: Evaluating the antitumor, survival, and adverse effects of hepatic arterial infusion chemotherapy using cisplatin in patients with advanced hepatocellular carcinoma and portal vein tumor thrombosis found no evidence of tumor progression or unacceptable toxicity.
2
•Journal Article
Study Protocol of the Japan NEN Registry: A Multicenter, Prospective Registry of Patients with Pancreatic, Gastrointestinal, Pulmonary, Bronchial, and Thymic Neuroendocrine Neoplasm
Toshihiko Masui,Tetsuhide Ito,Izumi Komoto,Shinsuke Kojima,Takuji Okusaka,Yasushi Ichikawa,Yusuke Kinugasa,Norihiro Kokudo,Atsushi Kudo,Akihiro Sakurai,Kenichi Sugihara,Hiroshi Date,Ken Haruma,Susumu Hijioka,Koichi Hirata,Hiro-o Yamano,Motohiro Sakamine,Takashi Kikuchi,Masanori Fukushima,Masayuki Imamura,Shinji Uemoto +20 more
TL;DR: This registration is proposed to provide real-time information on the status of NEN patients in Japan which has not been elucidated so far and allows quantitative, descriptive, and comparative analyses, which will evaluate associations among risk factors, treatment, and outcomes for NEN in Japan.
2
A multicenter phase II trial of S-1 with concurrent radiotherapy for locally advanced pancreatic cancer.
Tatsuya Ioka,Masataka Ikeda,Yoshinori Ito,N. Yonemoto,Michitaka Nagase,Kenji Yamao,Hiroyuki Miyakawa,Keiko Sato,Toshihiko Sato,Takuji Okusaka +9 more
TL;DR: The aim of this trial was to evaluate the efficacy and toxicity of S-1 and concurrent radiotherapy for locally advanced pancreatic cancer (PC) and to establish a protocol for future studies.
2